Barinthus Biotherapeutics plc - American Depositary Shares (BRNS) earnings
BRNS earnings moved a median of +0.13% by the close. Quarterly and annual BRNS reports and results, each read against the price at its own news timestamp. Back to the BRNS overview →
13 measured BRNS earnings events.
Where these BRNS earnings landedvs 13 measured BRNS earnings reactions
| Middle 50% of BRNS earnings reactions | -0.88% to +6.56% |
|---|---|
| Median reaction (to close) | +0.13% |
| Measured reactions | 13 |
Point-in-time · zero look-ahead
Half of the 13 BRNS earnings events with a measured close landed between -0.88% and +6.56%; 62% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments | Press release | +0.00% | -0.88% | |
| Form 10-Q Barinthus Biotherapeutic For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -0.88% | |
| Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments | Press release | +4.38% | +6.56% | |
| Form 10-Q Barinthus Biotherapeutic For: Mar 31 | SEC filing · Form 10-Q | +4.38% | +6.56% | |
| Form 10-K Barinthus Biotherapeutic For: Dec 31 | SEC filing · Form 10-K | +0.00% | +6.61% | |
| Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments | Press release | -2.08% | -10.83% | |
| Form 10-Q Barinthus Biotherapeutic For: Sep 30 | SEC filing · Form 10-Q | -2.08% | -10.83% | |
| Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments | Press release | +0.00% | +13.28% | |
| Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments | Press release | — | +0.13% | |
| Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results | Press release | — | +0.11% | |
| Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results | Press release | — | +1.46% | |
| Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments | Press release | — | +0.64% | |
| Barinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Developments | Press release | +2.97% | -0.33% |
Keep exploring
More BRNS: analyst actions → · SEC filings → · BRNS overview →